Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

Harlander M, Barrecheguren M, Turel M, Miravitlles M.

COPD. 2017 Jul 26:1-4. doi: 10.1080/15412555.2017.1342233. [Epub ahead of print]

PMID:
28745524
2.

The variability of respiratory symptoms and associated factors in COPD.

Miravitlles M, Izquierdo JL, Esquinas C, Pérez M, Calle M, López-Campos JL, Rodríguez González-Moro JM, Casanova C, Esteban C, de Lucas P.

Respir Med. 2017 Aug;129:165-172. doi: 10.1016/j.rmed.2017.06.017. Epub 2017 Jun 26.

PMID:
28732827
3.

Taken to task: what is and is not an appropriate response to an ERS guidelines task force?

Joos G, Bush A, Burghuber OC, Robalo Cordeiro C, Gaga M, Gibson GJ, Gratziou C, Rigau D, Rohde G, Smyth D, Stolz D, Tonia T, Vestbo J, Welte T, Brusselle G, Miravitlles M.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700952. doi: 10.1183/13993003.00952-2017. Print 2017 Jul. No abstract available.

PMID:
28705948
4.

Palliative care and prognosis in COPD: a systematic review with a validation cohort.

Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 9;12:1721-1729. doi: 10.2147/COPD.S135657. eCollection 2017.

5.

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.

Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, Esquinas C, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1683-1694. doi: 10.2147/COPD.S137852. eCollection 2017.

6.

Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?

Miravitlles M, Anzueto A.

Int J Mol Sci. 2017 Jun 23;18(7). pii: E1344. doi: 10.3390/ijms18071344. Review.

7.

Optimizing bronchodilation in the prevention of COPD exacerbations.

Miravitlles M, Anzueto A, Jardim JR.

Respir Res. 2017 Jun 20;18(1):125. doi: 10.1186/s12931-017-0601-2. Review.

8.

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study.

Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D.

NPJ Prim Care Respir Med. 2017 Jun 8;27:17004. doi: 10.1038/npjpcrm.2017.4.

PMID:
28631719
9.
10.

Bronchiectasis in COPD patients: more than a comorbidity?

Martinez-Garcia MA, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 May 11;12:1401-1411. doi: 10.2147/COPD.S132961. eCollection 2017.

11.

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.

Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svancara J, Sorli J, Krams A, Miravitlles M, Valipour A.

Eur Respir J. 2017 May 11;49(5). pii: 1601446. doi: 10.1183/13993003.01446-2016. Print 2017 May.

12.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2017 May 8. pii: S0300-2896(17)30092-3. doi: 10.1016/j.arbres.2017.04.002. [Epub ahead of print] English, Spanish.

13.

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Antonio Riesco J, Simonet P, Rigau D, Soriano JB, Ancochea J.

Arch Bronconeumol. 2017 Jun;53(6):324-335. doi: 10.1016/j.arbres.2017.03.018. Epub 2017 May 3. English, Spanish.

14.

Diagnosis of asthma-COPD overlap: the five commandments.

Miravitlles M.

Eur Respir J. 2017 May 1;49(5). pii: 1700506. doi: 10.1183/13993003.00506-2017. Print 2017 May. No abstract available.

PMID:
28461307
15.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, Plaza V.

Eur Respir J. 2017 May 1;49(5). pii: 1700068. doi: 10.1183/13993003.00068-2017. Print 2017 May. No abstract available.

PMID:
28461301
16.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

PMID:
28461299
17.

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study.

Voorham J, Vrijens B, van Boven JF, Ryan D, Miravitlles M, Law LM, Price DB.

Pragmat Obs Res. 2017 Apr 18;8:31-41. doi: 10.2147/POR.S132658. eCollection 2017.

18.

Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics.

Ramon MA, Esquinas C, Barrecheguren M, Pleguezuelos E, Molina J, Quintano JA, Roman-Rodríguez M, Naberan K, Llor C, Roncero C, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 13;12:1173-1181. doi: 10.2147/COPD.S128234. eCollection 2017.

19.

GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.

Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, Somfay A, Zykov K, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Tkacova R.

Eur Respir J. 2017 Apr 26;49(4). pii: 1602518. doi: 10.1183/13993003.02518-2016. Print 2017 Apr. No abstract available.

PMID:
28446560
20.

Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study.

Monteagudo M, Roset M, Rodriguez-Blanco T, Muñoz L, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 12;12:1145-1152. doi: 10.2147/COPD.S131016. eCollection 2017.

Supplemental Content

Loading ...
Support Center